CN109447830A - A method of it is issued for controlling drug - Google Patents
A method of it is issued for controlling drug Download PDFInfo
- Publication number
- CN109447830A CN109447830A CN201811282860.3A CN201811282860A CN109447830A CN 109447830 A CN109447830 A CN 109447830A CN 201811282860 A CN201811282860 A CN 201811282860A CN 109447830 A CN109447830 A CN 109447830A
- Authority
- CN
- China
- Prior art keywords
- patient
- drug
- medication
- rule module
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q40/00—Finance; Insurance; Tax strategies; Processing of corporate or income taxes
- G06Q40/08—Insurance
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
Landscapes
- Engineering & Computer Science (AREA)
- Business, Economics & Management (AREA)
- Health & Medical Sciences (AREA)
- Finance (AREA)
- Accounting & Taxation (AREA)
- Epidemiology (AREA)
- Economics (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Development Economics (AREA)
- General Health & Medical Sciences (AREA)
- Marketing (AREA)
- Strategic Management (AREA)
- Technology Law (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The present invention provides a kind of method issued for controlling drug, and this method comprises the following steps: being guided based on the high level drug operation that prefectures and cities issue and generates general rule module;Successfully to apply for that the patient of medication qualification sets up personal account, personal account is based on patient basis and sets up;Based on patient basis and diagnostic result and general rule module selection drug and dosage are combined, generates electronic prescription and personal rule module, and electronic prescription is associated with personal rule module to the account of corresponding patient;When patient's subsequent application medication, it is based on patient basis and newest diagnostic result, new electronic prescription is generated with personal rule module in conjunction with general rule module and is associated with to the account of corresponding patient, and personal rule module is updated.The present invention will issue carry out control from source, that is, prescription, track to the whole medication of patient, improve the efficiency of management, reduce patient and doctor, medical insurance handling institution, the contradiction between pharmacy.
Description
Technical field
The invention is related to a kind of method issued for controlling drug, and in particular to it is a kind of control from drug issue to
Patient purchases the method issued in medicine whole process by multiple crucial control section control drugs.
Background technique
At this stage, with more and more medical insurance directory is included into for this kind of high level drug of tumour medicine, radix is faced
Huge patients cause medical insurance handling institution that need to put into a large amount of medical insurance fund.However this similar drug has stringent adaptation
Disease easily causes medical insurance fund largely to waste once patient but still takes the drug drug resistance, tolerance.It is effective and reasonable
By medical insurance fund using maximizing, needs to excavate a set of drug fining control charging method efficiently managed, medical insurance fund is utilized
It maximizes.
The handling institution of medical insurance at present, as application materials, the medium of audit data, passes through hair by simple paper material
Put transmitting and information sharing that treatment card carries out patient's membership data.After final medical insurance audit, special by patient protects membership information
Typing medical insurance card, patient swipes the card purchase medicine after need to registered in treatment.Medical insurance handling institution is by purchasing medicine sum, total course for the treatment of year
Or total amount carries out special medicinal medicine control expense, reduces the waste of medical insurance fund to a certain extent, and effectively raises patient's money
The cost of lattice cost.
Lack the all-the-way tracking to patient medication in prior art, only carries out the method for control of binding.So
And the waste of medical insurance fund often generates during the medication of patient, present scheme is difficult to supervise patient's Life cycle
Medication process, and it is difficult to the personalized difference medication of real control patient, it can not be rationally effectively according to according to different
Patient distinguishes medication;It can not control medication state in time: effectively, drug resistance or tolerance;Can not be promoted according to drug matching,
Medication rule carries out reasonably issuing drug.So necessarily causing efficiently utilize medical insurance fund, cause largely to waste.
Summary of the invention
Goal of the invention: aiming at the above problems existing in the prior art, the present invention provides one kind and issues for controlling drug
Method.
Technical solution: of the present invention to include the following steps: that (1) is based on prefectures and cities for controlling the method that drug is issued
The high level drug operation issued, which is guided, generates general rule module;It (2) is successfully to apply for that the patient of medication qualification sets up a acknowledge a debt
Family, personal account are based on patient basis and set up;(3) based on patient basis and diagnostic result and in conjunction with general rule
Module selects drug and dosage, generates electronic prescription and personal rule module;(4) by the electronic prescription and personal rule module
It is associated with to the account of corresponding patient;(5) when the medication of patient's subsequent application, patient basis and newest diagnostic result, knot are based on
It closes the general rule module and generates new electronic prescription with personal rule module and be associated with to the account of corresponding patient, and to individual
Rule module is updated.
Further, in step (2), the patient basis includes: name, identification card number, age, gender, body
High, weight and body surface area.
Further, step (2) further comprises that the head portrait for the patient that medication qualification is successfully applied in typing and patient specify
1~3 neck medicine people head portrait and be associated with to patient personal account, for when taking medicine with patient or neck medicine people identity card and
Recognition of face is matched, and successful match then allows to purchase medicine and leads medicine, otherwise mustn't purchase medicine.
Further, in step (3), generating electronic prescription further comprises: extracting patient basis and diagnosis knot
Keyword in fruit is sent to general rule module;General rule module determines that patient's is unavailable based on received keyword
Drug, and be in the unavailable drug and forbid selected state;Doctor is chosen by input equipment in permission selected state
Particular medication, there are the medicines of incompatibility with the drug that is identified for the general module selected drug of identification doctor and determination
Product, and make to be in there are the drug of incompatibility and forbid selected state;General rule module is based on from patient basis and examines
The keyword extracted in disconnected result determines each medication maximum dose that the patient takes the particular medication and total medication most
Large dosage, and be in the dose value beyond each medication maximum dose and total medication maximum dose and forbid selected state;Doctor
Pass through each dosage and total dosage of the input equipment selection in the particular medication for allowing selected state;It is based on
Drug issues time, selected drug, each dosage of each selected drug and total dosage and generates electronic prescription.
Further, in step (3), generating personal rule module further comprises: based on institute in this electronic prescription
It writes a prescription and product and is determined to application amount the time that drug has been taken;Based on product combination general rule mould write a prescription in this electronic prescription
Block determines that there are the drugs of incompatibility when next time applies for medication;Determine that total value is submitted an expense account in the medical insurance of patient based on patient basis
Or drug reimbursement total quantity;Trigger condition is arranged: trigger condition one includes that patient applies for purchase next time medicine, and trigger condition two includes
Patient successfully apply next time purchase medicine after doctor's prescription when;Triggering result when meeting each trigger condition is set, comprising: when
Reach trigger condition for the moment, the time phase difference for judging that patient apply for whether the time of purchase medicine has taken with this drug next time is certain
In threshold range;If allowing purchase next time medicine in threshold range, otherwise forbid purchase next time medicine;When reaching trigger condition two
When, will next time application medication when with this purchase medicine there are the drugs of incompatibility to be set as forbidding selected state;And it calculates in real time
The total value of patient's current year purchased drug judges whether to reach medical insurance reimbursement total value or drug reimbursement total quantity, if reaching
For forbidding medical insurance to purchase medicine beyond part;Personal rule module is generated based on trigger condition and triggering result.
The utility model has the advantages that helping to cure compared with prior art, the present invention (1) can effectively carry out drug Precise control
It protects handling institution and medical insurance fund is utilized into maximization;(2) can effectively reduce prescription issue in the medicine due to caused by resistance problems
Product waste;(3) effectively supervision and actively control can be carried out to the process that doctor writes a prescription;(4) by the crucial control section in system
Point combines with the whole medication of patient tracking, issues carry out control from source, that is, prescription, improves the efficiency of management, reduces and suffer from
Person and doctor, medical insurance handling institution, the contradiction between pharmacy.
Detailed description of the invention
Fig. 1 is of the invention for controlling the flow chart for the method that drug is issued.
Specific embodiment
It is that the present invention is described in detail in conjunction with attached drawing below.
A method of it is issued for controlling drug, work step is as follows:
Step 1: the high level drug operation issued according to prefectures and cities is guided, by medication rule, auditing standards, audit material etc.
In key message input system, general rule module is generated.It is issued to realize that medication source is i.e. square, carries out control management.
Simultaneity factor automatically generates medication qualification examination and evaluation mechanism, is that doctor judges whether have medication qualification according to patient information
Data branch is provided.The generation of general rule module can be accomplished by the following way: determine that the operation of high level drug is every in guiding
Rule trigger condition and meet the operation needed to be implemented after the trigger condition, i.e., triggering result.Wherein, trigger condition can be with
It is various opportunitys, such as when doctor is when drug is issued and inquires corresponding patient information on platform and be prepared as its prescription, or
Person is certain nomenclature of drug etc. that doctor is just inputting in prescription.Triggering result can be instruction.Finally, by trigger condition
Mapping table, which is generated, with triggering result pairing searches calling for processor.
Step 2: for applying for that the patient of medication qualification needs to judge to judge whether it has use according to auditing standards for the first time
Medicine qualification.Typing patient basis is needed when determining has medication qualification, includes height, weight, BSA (body surface area)
Deng as Some Drugs to the foundation for carrying out targetedly evolution required in differences of Physiological;According to the essential information of patient
Personal account is set up for patient, while 1~3 neck medicine that the head portrait of the patient of medication qualification and patient are specified successfully is applied in typing
The head portrait of people is simultaneously associated with to the personal account of patient, for carrying out when taking medicine with patient or neck medicine people identity card and recognition of face
Matching, successful match then allow to purchase medicine and lead medicine, otherwise mustn't purchase medicine.
Step 3: based on patient basis and diagnostic result and combining general rule module selection drug and dosage, generate
Electronic prescription and personal rule module.
Specifically, generation electronic prescription further comprises: firstly, extracting the pass in patient basis and diagnostic result
Key word is sent to general rule module, and general rule module determines the unavailable drug of patient based on received keyword, and makes
The unavailable drug, which is in, forbids selected state.At this moment, doctor can only be in permission selected state by input equipment
Particular medication is selected in drug.
Then, there are incompatibility with the drug that is identified for the general rule module selected drug of identification doctor and determination
Drug, and make there are the drug of incompatibility be in forbid selected state.Meanwhile general rule module is based on basic from patient
The keyword extracted in information (including gender, age, height, weight and BSA) and diagnostic result determines that the patient takes institute
The each medication maximum dose and total medication maximum dose of particular medication are stated, and is made beyond each medication maximum dose and total medication
The dose value of maximum dose, which is in, forbids selected state.At this point, doctor can only select to be in by input equipment to be allowed to choose shape
The each dosage and total dosage of the particular medication of state.Preferably, forbid choosing shape when drug or metering are in
When state, system also prompts to illustrate drug or metering in the reason of forbidding selected state.
Finally, when doctor selected it is all needed for drugs and after to application amount, system is based on drug and issues time, selected medicine
Product, each dosage of each selected drug and total dosage generate electronic prescription.In a preferred embodiment, default
It issues every time time no more than one month that total dosage of drug maintains.
Generating the crucial of personal rule module is the multiple triggering control nodes of setting in fact.It specifically includes: firstly, based on this
Write a prescription product and is determined to application amount the time that drug has been taken in secondary electronic prescription;Based on write a prescription product in this electronic prescription
There are the drugs of incompatibility when determining that next time applies for medication in conjunction with general rule module;Patient is determined based on patient basis
Medical insurance reimbursement total value or drug reimbursement total quantity.Then, trigger condition (i.e. triggering control node): trigger condition one is set
Including patient apply next time purchase medicine, trigger condition two include patient successfully apply next time purchase medicine after doctor's prescription when.Then,
Triggering result when meeting each trigger condition is set, comprising: when reaching trigger condition for the moment, judges that patient applies purchasing medicine next time
The certain threshold range of time phase difference whether taken with this drug of time in;If in threshold range, under allowing
Otherwise secondary purchase medicine forbids purchase next time medicine.When reaching trigger condition two, will next time application medication when with this purchase medicine there are compatibilities
The drug of taboo is set as forbidding selected state;And the total value of patient's current year purchased drug is calculated in real time, judge whether to reach
Total value or drug reimbursement total quantity are submitted an expense account in medical insurance, for forbidding medical insurance to purchase medicine beyond part if reaching.Finally, based on triggering
Condition and triggering result generate personal rule module, and the electronic prescription of generation is associated with personal rule module to corresponding patient
Account.Preferably, when drug, which is in, forbids selected state, system also prompts to illustrate that drug is in the original for forbidding selected state
Cause.
Step 4: when patient's subsequent application medication, patient basis and newest diagnostic result are based on, in conjunction with described general
Rule module generates new electronic prescription with personal rule module and is associated with to the account of corresponding patient, and to personal rule module into
Row updates.
Specifically, patient is during subsequent purchase medicine, and issuing process to prescription in addition to can trigger general rule module controls
Except system, the control of personal rule module is also triggered, mainly there is following four situation:
Trigger condition one: when patient applies purchasing medicine again.
At this point, system first can system by patient medication information, intelligence computation goes out drug surplus in patient's hand, thus really
Surely it whether there is and have the case where drug has not been taken and applied for purchase medicine in patient's hand.When still there is non-dose drug in hand
When, which is changed into frozen state automatically by system, i.e., patient again to responsibility physician visits when, can not issue at electronics
Side carries out control from source.
System also judges patient and this time applies for whether purchase medicine (non-to purchase medicine for the first time) closes on the phase of reexamining.According to national policy mark
Standard, the medication of high level drug need to periodically reexamine.Therefore, when system is determined that distance reexamines the phase relatively closely (usually less than one
Month) when, system intelligence computation goes out distance and reexamines maximum dosage required for the phase, and makes the dosage beyond maximum always dosage
Selective value, which is in prohibit, selects state, thus the fund waste generated after the product that utmostly avoid more writing a prescription by drug resistance.
Trigger condition two: patient successfully apply next time purchase medicine after doctor's prescription when.
Firstly, personal rule module triggering, so that there are the drugs of incompatibility and corresponding agent with previous purchased drug
Amount is in automatically forbids selected state.So, so that it may avoid waste caused by drug qualification mutual exclusion.
Then doctor issues electronic prescription, product required for choosing and corresponding dosage and total medication dose every time.This
When, general rule module and personal rule module work simultaneously.After system identification goes out the selected drug of doctor, for general
For rule module, the keyword extracted based on the selected drug of doctor and diagnostic result judges whether there is other drugs pair
It is unavailable for the current state of patient, and be in unavailable drug and forbid selected state, alternatively, general rule module is based on
The selected drug of doctor judge other drugs whether with selected drug there are incompatibility, and make the drug there are incompatibility
In forbidding selected state.For personal rule module, first determine whether patient this time purchases medicine (non-to purchase medicine for the first time)
Close on the phase of reexamining.According to national policy standard, the medication of high level drug need to periodically reexamine.Therefore, when personal rule module is true
Set a distance reexamine phase relatively nearly (usually less than one month) when, issue message to system.System intelligence computation goes out distance and reexamines the phase
Required maximum dosage, and so that the dosage selective value beyond maximum total dosage is in taboo and select state, thus maximum journey
Spend the fund waste generated after avoiding more writing a prescription product by drug resistance.Then, the drug that personal rule module is inputted also according to doctor
And whether dosage real-time judge patient's year in this year purchased drug total value has reached or more than medical insurance total amount.Once being more than to bind
It controls the size and terminates medical insurance fund and want medication.Preferably, when drug, which is in, forbids selected state, system also prompts to illustrate drug
In the reason of forbidding selected state.
Step 5: after patient completes purchase medicine, system automatically generated medication record, and purchase next time medicine is calculated according to medication rule
The information such as date, dosage, the tracking patient medication situation of Life cycle;
Step 6: periodically tracking and record patient medication situation, introduce intelligence and study and judge mechanism, patient medication is carried out super resistance to
The dynamic evaluation such as the analysis of medicine phase, disease progression monitoring, avoid invalid medicining condition.
Claims (5)
1. a kind of method issued for controlling drug, which comprises the steps of:
(1) it is guided based on the high level drug operation that prefectures and cities issue and generates general rule module;
It (2) is successfully to apply for that the patient of medication qualification sets up personal account, personal account is based on patient basis and sets up;
(3) it based on patient basis and diagnostic result and combination general rule module selection drug and dosage, generates at electronics
Side and personal rule module, and the electronic prescription is associated with personal rule module to the account of corresponding patient;
(4) when the medication of patient's subsequent application, it is based on patient basis and newest diagnostic result, in conjunction with the general rule module
New electronic prescription is generated with personal rule module to be associated with to the account of corresponding patient, and personal rule module is updated.
2. according to claim 1 for controlling the method that drug is issued, which is characterized in that in step (2), the trouble
Person's essential information includes: name, identification card number, age, gender, height, weight and body surface area.
3. according to claim 1 for controlling the method that drug is issued, which is characterized in that step (2) further comprises
Typing is successfully applied for the head portrait for 1~3 neck medicine people that the head portrait of the patient of medication qualification and patient are specified and is associated with to patient's
Personal account, for matching when taking medicine with patient or neck medicine people identity card and recognition of face, successful match then allows to purchase
Medicine simultaneously leads medicine, otherwise mustn't purchase medicine.
4. according to claim 1 for controlling the method that drug is issued, which is characterized in that in step (3), generate electricity
Sub- prescription further comprises:
The keyword in patient basis and diagnostic result is extracted, general rule module is sent to;General rule module is based on
Received keyword determines the unavailable drug of patient, and is in the unavailable drug and forbids selected state;
Doctor is chosen by input equipment in the particular medication for allowing selected state, and general module identifies the selected medicine of doctor
There are the drugs of incompatibility for product and determination and the drug identified, and make to be in there are the drug of incompatibility and forbid choosing shape
State;
General rule module determines that the patient takes institute based on the keyword extracted from patient basis and diagnostic result
The each medication maximum dose and total medication maximum dose of particular medication are stated, and is made beyond each medication maximum dose and total medication
The dose value of maximum dose, which is in, forbids selected state;
Each dosage and total medication of the doctor by input equipment selection in the particular medication for allowing selected state
Dosage;
Time, selected drug, each dosage of each selected drug and total dosage, which are issued, based on drug generates electronics
Prescription.
5. according to claim 1 for controlling the method that drug is issued, which is characterized in that in step (3), generate a
People's rule module further comprises:
The time that drug has been taken is determined based on write a prescription product in this electronic prescription and to application amount;
There are incompatibility when determining that next time applies for medication based on product combination general rule module write a prescription in this electronic prescription
Drug;
The medical insurance reimbursement total value or drug reimbursement total quantity of patient are determined based on patient basis;
Trigger condition is arranged: trigger condition one includes that patient applies for purchase next time medicine, and trigger condition two includes under patient successfully applies
After secondary purchase medicine when doctor's prescription;
Triggering result when meeting each trigger condition is set, comprising:
When reaching trigger condition for the moment, judge that patient apply for the time phase whether taken with this drug of time of purchase medicine next time
In poor certain threshold range;If allowing purchase next time medicine in threshold range, otherwise forbid purchase next time medicine;
When reaching trigger condition two, will next time application medication when with this purchase medicine there are the drugs of incompatibility to be set as forbidding
Selected state;And the total value of patient's current year purchased drug is calculated in real time, judge whether to reach medical insurance reimbursement total value or drug
Total quantity is submitted an expense account, for forbidding medical insurance to purchase medicine beyond part if reaching;
Personal rule module is generated based on trigger condition and triggering result.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811282860.3A CN109447830A (en) | 2018-10-31 | 2018-10-31 | A method of it is issued for controlling drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811282860.3A CN109447830A (en) | 2018-10-31 | 2018-10-31 | A method of it is issued for controlling drug |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109447830A true CN109447830A (en) | 2019-03-08 |
Family
ID=65550106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811282860.3A Pending CN109447830A (en) | 2018-10-31 | 2018-10-31 | A method of it is issued for controlling drug |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109447830A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111180035A (en) * | 2019-12-31 | 2020-05-19 | 上海亿保健康管理有限公司 | Medicine information processing method, device and equipment |
CN113450904A (en) * | 2020-03-24 | 2021-09-28 | 北京平安联想智慧医疗信息技术有限公司 | Apparatus, system and method for assessing medical behavior |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103902791A (en) * | 2011-12-20 | 2014-07-02 | 西安福安创意咨询有限责任公司 | Clinic safe and reasonable drug use decision supporting method |
CN104398387A (en) * | 2014-06-23 | 2015-03-11 | 罗伯特·葛伦 | Intelligent medicine taking reminding and controlling device and method |
CN104487972A (en) * | 2014-09-29 | 2015-04-01 | 曹庆恒 | Multidimensional medication information processing method, system and device |
CN106530166A (en) * | 2016-08-31 | 2017-03-22 | 中国人民解放军总医院第附属医院 | Hospital medical insurance expense nonpayment prevention auxiliary management information system and nonpayment prevention method |
WO2017139761A1 (en) * | 2016-02-12 | 2017-08-17 | Valentine Edmund L | Opioid+device combination products with improved safety and efficacy profiles |
CN107451401A (en) * | 2017-07-11 | 2017-12-08 | 武汉金豆医疗数据科技有限公司 | A kind of medical insurance intelligent checks method and system |
CN107767927A (en) * | 2017-11-16 | 2018-03-06 | 深圳市捷迅高新科技股份有限公司 | A kind of Electronic Prescription System and its electronic health record |
CN108022365A (en) * | 2017-12-11 | 2018-05-11 | 吕刚 | Self-service medicine selling machine based on fingerprint identification technology and self-service sell medicine system |
CN108172302A (en) * | 2017-12-15 | 2018-06-15 | 广州市康软信息科技有限公司 | Rational use of medicines information monitoring method and system |
-
2018
- 2018-10-31 CN CN201811282860.3A patent/CN109447830A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103902791A (en) * | 2011-12-20 | 2014-07-02 | 西安福安创意咨询有限责任公司 | Clinic safe and reasonable drug use decision supporting method |
CN104398387A (en) * | 2014-06-23 | 2015-03-11 | 罗伯特·葛伦 | Intelligent medicine taking reminding and controlling device and method |
CN104487972A (en) * | 2014-09-29 | 2015-04-01 | 曹庆恒 | Multidimensional medication information processing method, system and device |
WO2017139761A1 (en) * | 2016-02-12 | 2017-08-17 | Valentine Edmund L | Opioid+device combination products with improved safety and efficacy profiles |
CN106530166A (en) * | 2016-08-31 | 2017-03-22 | 中国人民解放军总医院第附属医院 | Hospital medical insurance expense nonpayment prevention auxiliary management information system and nonpayment prevention method |
CN107451401A (en) * | 2017-07-11 | 2017-12-08 | 武汉金豆医疗数据科技有限公司 | A kind of medical insurance intelligent checks method and system |
CN107767927A (en) * | 2017-11-16 | 2018-03-06 | 深圳市捷迅高新科技股份有限公司 | A kind of Electronic Prescription System and its electronic health record |
CN108022365A (en) * | 2017-12-11 | 2018-05-11 | 吕刚 | Self-service medicine selling machine based on fingerprint identification technology and self-service sell medicine system |
CN108172302A (en) * | 2017-12-15 | 2018-06-15 | 广州市康软信息科技有限公司 | Rational use of medicines information monitoring method and system |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111180035A (en) * | 2019-12-31 | 2020-05-19 | 上海亿保健康管理有限公司 | Medicine information processing method, device and equipment |
CN113450904A (en) * | 2020-03-24 | 2021-09-28 | 北京平安联想智慧医疗信息技术有限公司 | Apparatus, system and method for assessing medical behavior |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102180079B1 (en) | A method and system for providing of health care service using block-chain | |
US20220351817A1 (en) | Blockchain prescription management system | |
Bell et al. | Choroidal melanoma: natural history and management options | |
US20170185723A1 (en) | Machine Learning System for Creating and Utilizing an Assessment Metric Based on Outcomes | |
CN109147198B (en) | Self-service medicine selling method and system | |
US20080162496A1 (en) | System and method for centralized management and monitoring of healthcare services | |
CN108986879A (en) | Drug recommended method, device, computer equipment and storage medium | |
Mariados et al. | Hyaluronic acid spacer for hypofractionated prostate radiation therapy: A randomized clinical trial | |
CN109273098B (en) | Medicine curative effect prediction method and device based on intelligent decision | |
CN107958708A (en) | Risk trend appraisal procedure and system after institute | |
EP3991173A1 (en) | Systems and methods for prescription and dosing of therapeutic stimuli using recorded guarantees | |
JPWO2019244949A1 (en) | Biometric information processing methods, biometric information processing devices, and biometric information processing systems | |
CN107273709A (en) | Computer based hospital patient data processing method | |
EP1444623A1 (en) | Prescription fulfillment system and method | |
US20230118275A1 (en) | System and method for healthcare security and interoperability | |
CN109447830A (en) | A method of it is issued for controlling drug | |
CN109377388A (en) | Medical insurance is insured method, apparatus, computer equipment and storage medium | |
CN107895593A (en) | Data processing method and related product | |
US20140019100A1 (en) | Radiation treatment planning apparatus and method thereof | |
Etter et al. | Health care expenditures after introduction of a gatekeeper and a global budget in a Swiss health insurance plan. | |
CN106485628B (en) | Army Hospital medical record information system and its management method under DRGs way of paying | |
US11823782B2 (en) | Systems, methods, apparatuses, and computer program products for administering pain management solutions remotely | |
France | Health technology assessment in Italy | |
CN107993708A (en) | A kind of respiratory disorder intelligence diagnosis and therapy system and control application method | |
US20190164636A1 (en) | National patient pharmacy identifier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190308 |
|
RJ01 | Rejection of invention patent application after publication |